Crystal Pharmatech, a China-US CRO, Raises $10 Million from Renren

Crystal Pharmatech, a Suzhou-New Jersey clinical research organization, raised $10 million in a Series A round led by Renren Lianhe Holdings, the investment arm of China social media company Renren. Crystal Pharmatech will use the funds to develop its drug development operation, which centers on materials science along with solid drug screening and evaluation. More details.... Share this with colleagues: // //